Fleten, Karianne Giller
Eksteen, J. Johannes
Mauseth, Brynjar
Camilio, Ketil André
Vasskog, Terje
Sveinbjørnsson, Baldur
Rekdal, Øystein
Mælandsmo, Gunhild M.
Flatmark, Kjersti
Funding for this research was provided by:
Norges Forskningsråd (254800/O30)
Kreftforeningen (197837)
Article History
Received: 27 November 2020
Accepted: 23 February 2021
First Online: 24 March 2021
Competing interests
: BM is an employee of Lytix Biopharma AS. ØR, BS, and KAC are employees and shareholders in Lytix Biopharma AS. The other authors declare no competing interests.